Kala Azar | 28 Feb 2024
Why in News?
India achieved significant progress in eliminating Kala Azar (KA), reporting less than one case per 10,000 population in 2023, compared to previous years.
- Data from the National Vector Borne Disease Control Programme revealed a decline in Kala Azar cases, with 595 cases and four deaths reported in 2023 compared to 891 cases and three deaths in 2022.
Note:
- India has not yet eliminated KA but has made substantial progress towards its elimination goal.
- India’s initial target year for Kala Azar elimination was 2010, which was later extended to 2015, 2017, and then 2020.
- The WHO defines elimination for KA as having fewer than one case per 10,000 people at the sub-district (block Primary Health Centres) level in India. Once achieved, the elimination is to be sustained for 3 years for KA elimination certification.
- India will need to sustain this momentum over the next three years to receive WHO certification, considering that India has missed at least four deadlines for Kala Azar elimination.
- In Oct 2023, Bangladesh became the first country, globally, to be officially validated by the WHO for eliminating Kala Azar as a public health problem.
What are the Key Facts About Kala Azar?
- About:
- Kala-azar (visceral leishmaniasis), also known as Black Fever is a fatal disease caused by a protozoan parasite Leishmania donovani.
- Symptoms:
- It is characterised by irregular bouts of fever, weight loss, enlargement of the spleen and liver, and anaemia.
- Prevalence:
- Most cases occur in Brazil, east Africa and India. An estimated 50,000 to 90 000 new cases of VL occur worldwide annually, with only 25-45% reported to WHO. It has an outbreak and mortality potential.
- Transmission:
- Leishmania parasites spread through bites of infected female sandflies, feeding on blood for egg production. Over 70 animal species, including humans, can carry these parasites.
- Major Risk Factors:
- Poverty, poor housing, and sanitation.
- Diets lacking essential nutrients.
- Movement into high-transmission areas.
- Urbanisation, deforestation, climate change.
- Diagnosis and Treatment:
- Suspected visceral leishmaniasis cases require immediate medical attention. Diagnosis involves clinical signs combined with parasitological or serological tests.
- Left untreated, it can be fatal in 95% of cases.
- Suspected visceral leishmaniasis cases require immediate medical attention. Diagnosis involves clinical signs combined with parasitological or serological tests.
- Prevention and Control:
- Early diagnosis and prompt treatment are crucial in reducing disease prevalence, and preventing disabilities, and death.
- Vector control, such as insecticide spray and the use of insecticide-treated nets, helps reduce transmission by decreasing the number of sandflies.
- Effective disease surveillance is important for monitoring and acting during epidemics and high case fatality rates.
- Social mobilization and strengthening partnerships, including community education and collaboration with stakeholders, are critical for effective control.
- India’s Efforts to Control Kala Azar:
- The Government of India launched a centrally sponsored Kala-azar control program in 1990-91, which was later revised in 2015.
- The program aimed to eliminate Kala-azar by 2023, aligning with the WHO neglected tropical diseases (NTDs) Roadmap goal of 2030.
- The National Vector Borne Disease Control Programme (NVBDCP), 2003 is an umbrella programme for prevention and control of vector borne diseases viz., malaria, lymphatic filariasis, kala azar, and chikungunya.
- Recent Efforts:
- Rigorous indoor residual spraying effort aimed at curtailing sandfly breeding sites; application of a special soil to seal crevices in mud walls, preventing sandflies from nesting.
- Pucca houses in KA-affected villages have been constructed under PMAY-G - A total of 25,955 houses in 2017-18 (1371 houses in Bihar & 24584 in Jharkhand).
- Mobilisation of the ASHA (Accredited Social Health Activist) network to ensure completion of treatment for PKDL patients, who require a 12-week course of Miltefosine (an antileishmanial agent).
- The Government of India launched a centrally sponsored Kala-azar control program in 1990-91, which was later revised in 2015.
Post-kala-azar Dermal Leishmaniasis (PKDL)
- PKDL is a skin condition that follows visceral leishmaniasis, causing rashes on the face, arms, and trunk.
- It affects mainly Sudan and the Indian subcontinent, with 5-10% of kala-azar patients developing it.
- PKDL may occur 6 months to a year after kala-azar treatment, potentially spreading Leishmania.
UPSC Civil Services Examination, Previous Year Questions (PYQs)
Prelims:
Q. Consider the following diseases: (2014)
- Diphtheria
- Chickenpox
- Smallpox
Which of the above diseases has/have been eradicated in India?
(a) 1 and 2 only
(b) 3 only
(c) 1, 2 and 3
(d) None
Ans: (b)